Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.
Adam
Ishag
I
New Halfa Teaching Hospital (Adam), Sudan. ishagadam@hotmail.com
Elbashir
Mustafa I
MI
D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D016778:Malaria, Falciparum / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D013413:Sulfadoxine / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine